Double-digit growth

Pharma cannot sustain the double-digit growth demanded by investors. When market exclusivity ends, revenues drop by 50-80%. 

As a consequence of all the aforementioned issues, the pharmaceutical industry cannot reasonably sustain its historic double-digit growth without... 

For the period until 2010, annual double-digit growth of chemicals output is projected for China and for Asia exduding China and Japan (Fig. 1.3). Since China is expected to remain a net importer of many chemicals far beyond 2010, this demand will also drive output growth in other regions where domestic demand is only increasing slowly. 

Mirasol F. Pharma industry is poised for double-digit growth. Chem Market Report 1998 253 14-16. 

Pikes Peak Coffee PPC) has consistently delivered double digit growth since its inception, except for the last three quarters. 

China s population of 1.3 billion (compared to 300 milhon in the United States) makes up more than 20% of the world s population. Current gross domestic product (GDP) is US 1.4 trillion and is projected to grow to US 43 trillion by 2050 at an annual rate of 8 to 10%. With 6% of that GDP expected to be spent on health care, China s pharmaceutical market is expected to be the only one that continues double-digit growth into 2010 ... 

It remains relatively in low volume, in the scale of polyolefins that we have primarily focused on, but provides unique properties and performance, and so continues with double-digit growth. 

The sales of Li-Ion cells are shown in Table 1.2. The Li-Ion market is very competitive. The data for the competing Ni-Cd and Ni-MH cells are included for comparison purposes. The market growth for Li-Ion is spectacular and driven by the proliferation of portable electronic devices such as notebook computers and cellular phone applications. In 15 years between 1991 and 2006 the sales and production of Li-Ion batteries experienced double-digit growth. The slower growth period, around 2000, occurred when cell production in China and Korea began to ramp up and may not have been included in the database. 

Many reasons such as lack of familiarity and the current, limited availability have so far prevented large-scale penetration of these materials into broader injection-molded markets. However, double-digit growth is still expected as large companies enter the market and technological advances are made [32]. 

BASF is Still the sole producer of PY 138. The company is backward integrated in the synthesis of the key intermediate 8-aminoquinaldine, which is part of the BASF Verbund . Excellent technical properties and a competitive cost / performance ratio have formed the basis for the success of PY 138 since its introduction. A new 1000 tonnes/year plant came on stream in Ludwigshafen in 1999. The unit, which consists of two closed production lines connected in series, replaces an older line of lower capacity. It is managed by modern process control equipment and produces no effluent. This investment will help to satisfy the demand for PY 138 grades, sales of which achieved double-digit growth rates in the field of high performance paints and the coloration of plastics in recent years. 

From 1982 (when the first recombinant product was approved) through 2008, there have been 403 approvals of biopharmaceutical products by FDA, including vaccines, blood products, recombinant proteins (including monoclonal antibodies (mAb)), and other biopharmaceuticals. Among these, 103 are recombinant proteins. The market for therapeutic proteins should show double-digit growth over the next few years. 

---